FOLH1 and neoplasm: Bouvet and colleagues developed the radiocompound 18F-DCFPyL, via direct radiofluorination, validated in a pre-clinical model, consisting of nude mice bearing LNCaP (PSMA+) and PC3 (PSMA−) tumor xenografts [30].